Chemotherapy After Surgery: — Why It Is Still Needed

A successful operation means the visible tumour was removed cleanly — it does not mean every cancer cell in the body was removed. Microscopic cells may have left the tumour site before surgery and are not detectable on any scan. Adjuvant chemotherapy addresses those cells. The two statements — the surgery went well, and chemotherapy is still recommended — are not contradictory. Both can be true at the same time, for the same reason.

This depends on your cancer type, your stage and the regimen your oncologist recommends. Adjuvant chemotherapy is typically given in cycles — a period of treatment followed by a rest, repeated over several months. Your oncologist will tell you the planned number of cycles before you start, so you have a clear timeline. The number reflects which regimen the evidence supports for your specific situation, not a measure of how serious the cancer is.

The decision is always yours, and your oncologist will not force it. What they will do is explain what the pathology shows and what the evidence suggests for your situation. Declining adjuvant chemotherapy means cells that may have already spread are left untreated. For some cancer types and stages, that difference is significant; for others, it is smaller. Ask what the recommendation is specifically based on — that conversation should inform the decision, not fear of side effects alone, which is a separate and manageable problem.

Not in the way you might expect. Adjuvant chemotherapy targets cells too small to appear on any scan, so there is no image that confirms it is working during treatment. The measure is whether the cancer stays away over time. Your oncologist will schedule follow-up appointments and scans after treatment ends to check for any signs of recurrence. Completing the full planned course is important — stopping early may reduce the intended benefit.

The medicines are given in similar ways, but the goal is different. Adjuvant chemotherapy after surgery is given when the intention is to prevent recurrence — there is no visible disease to reduce. Chemotherapy for cancer that has already spread to other organs is given to control or reduce visible disease. The distinction matters because the expected benefit and the decision-making are different in each situation. Your oncologist will describe the goal of your specific treatment so you understand what it is intended to achieve.

This is a reasonable question, and for certain cancer types and stages, surveillance without immediate adjuvant treatment is an accepted approach. For others, treatment given when only microscopic cells are present is more likely to be effective than treatment started after a full recurrence has developed. Your oncologist will tell you which situation applies to yours. If you are uncertain about the recommendation, asking for the reasoning behind it — or seeking a second opinion — is always appropriate before deciding.